Efficacy of Tegoprazan for Improving the Susceptibility of Antimicrobial Agents against Antibiotic-Resistant Helicobacter pylori

Background/Aims: Favorable outcomes of potassium-competitive acid blocker (PCAB)-containing eradication therapy have been reported. In fact, tegoprazan, a recently developed PCAB, was presumed to show good eradication efficacy even for resistant Helicobacter pylori. We aimed to investigate the anti-...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Jung Won Lee, Nayoung Kim, Ryoung Hee Nam, Jeong Eun Yu, Joo Hee Son, Sun Min Lee, Dong Ho Lee
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Gastroenterology Council for Gut and Liver 2021-01-01
Schriftenreihe:	Gut and Liver
Schlagworte:	helicobacter pylori potassium-competitive acid blocker eradication resistance
Online-Zugang:	http://gutnliver.org/journal/view.html?doi=10.5009/gnl20247
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!